Exact Sciences(US:EXAS) Globenewswire·2025-11-20 22:30Core Points - Class Action Attorney Juan Monteverde is investigating Exact Sciences Corporation in relation to its proposed sale to Abbott Laboratories, where shareholders are expected to receive $105.00 per common share [1] Group 1: Company Overview - Exact Sciences Corporation is under investigation by Monteverde & Associates PC regarding its sale to Abbott Laboratories [1] - The firm has a successful track record in recovering money for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] Group 2: Transaction Details - Under the terms of the proposed transaction, Exact Sciences shareholders are expected to receive $105.00 per common share [1] - The investigation raises questions about whether this deal is fair for shareholders [1]